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Treatment of cardiovascular disease, albeit under the auspices of other clinical descriptors to those described in western
biomedicine, has a long history in China. Chinese Medicine (CM) is guided by unique philosophical underpinnings and theories.
There are diﬀerences in how the heart is conceptualised traditionally in CM compared to biomedicine. This paper focusses
on how hypercholesterolemia is understood from within the Chinese medical paradigm, including its aetiology, pathogenesis,
and treatment. A brief overview of the key characteristics and theories of CM is given to provide context. Modern science
has demonstrated that many Chinese herbs have cholesterol-lowering properties. Examples of research into individual herbs
and medicinal formulae, combinations of herbs are presented. At a more sophisticated level, some researchers are challenging
some of the very assumptions upon which CM is based, including applicability of CM theory to modern clinical entities such as




the auspices of diﬀerent clinical descriptors to those used
in modern biomedicine. For example, in ancient China the
term “xiao ke” described “thirsting and wasting disorder”,
what is now known as diabetes. Whilst western biomedicine
coexists with CM within China, it remains that within the
ﬁeld of CM there is a unique understanding of the heart and
cardiovascular system that inﬂuences how CVD is treated
with Chinese herbal medicine and acupuncture. As new
clinical entities have emerged in modern times, and as CM
has sought to integrate with western medicine, CM theories
have been applied to understand and justify treatment of
such diseases or disorders. Hypercholesterolemia is one such
example—it is a biomedically deﬁned clinical entity, a risk
factor for CVD with no historical precedence of treatment
hundreds of years ago.
This paper discusses how hypercholesterolemia is under-
stood within CM, including aetiology, pathogenesis, and
treatment. It is necessary for the reader to have some under-
standing of the theoretical framework of CM, therefore I will
begin with a brief summary of the main guiding theories and
key characteristics of CM, along with a description of the
componentsofthecardiovascularsystem.Thereisincreasing
scientiﬁcevidencethatmanyChineseherbslowercholesterol
and have other positive eﬀects on the cardiovascular system;
information about individual herbs and medicinal formula
is included. Finally, there is a discussion about some creative
research that attempts to investigate potential intersections
of CM and western medicine, along with the merits of such
investigations.
It is important that the reader keep an open mind—
whilst some of the CM terminology may appear unsophis-
ticated and naive, in some ways this apparent simplicity
masks a profound complexity that takes years to understand
deeply and master. Unlike western medical language, much
of CM terminology was derived from everyday language. I
have, through necessity, simpliﬁed descriptions—this paper
has been written for western medical colleagues with a more
limited knowledge of CM. Note that the concept of an organ2 Cholesterol
diﬀers from the biomedical one, and so organ names are
capitalised when referred to within the context of CM.
2.ChineseMedicineFeaturesand
GuidingTheories
2.1. Features of Chinese Medicine. There are some important
distinguishing features of CM that set it aside, in particular,
from western medicine. It is underpinned by a worldview
that is materialistic and dialectic and an ideology of holism.
The notion of interdependence permeates the understanding
of the functioning of the organ systems within the body in
health and illness and describes the relationship between
humans and the environment. Flowing from the holistic
philosophy is the understanding of health as a reﬂection
of harmony: between humans and nature, between the
organ systems, tissues, and vital substances of the body, and
the mind and emotions [1]. Consideration is given to the
root cause (the “ben”) and the symptoms (the “branch”
or “biao”) of an illness, with treatment aiming to address
the root cause, not just the symptoms. Treatment also is
individualisedtothepatient,takingintoaccountsuchfactors
as constitution, age, gender, and season of occurrence of
the illness.
Another characteristic of the medicine has been to
diﬀerentiate diseases (or signs or symptoms) according to
underlying “patterns of disharmony”, termed syndromes.
Each syndrome is characterised by particular signs and
symptoms, reﬂective of the underlying pathogenesis at that
point in time. Treatment aims to treat both disease and
underlying syndromes. Chinese herbal medicines (CHMs),
typically combinations of 4–12 diﬀerent herbs, are usually
syndrome-speciﬁc. A CHM designed to treat one syndrome
will usually contain very diﬀerent herbs to a CHM designed
for another syndrome (of the same disease). Although this
syndrome diﬀerentiation has become thought of as a central
feature of CM during the last century, prior to this time
there are many recorded examples where reference is made
to simply treating the disease [2].
Chinese medicine diagnosis is based on collection of
clinical data and analysis of signs and symptoms according
to several CM theories to arrive at a diagnosis of the
disease/disorder and its underlying CM syndrome. The
four main diagnostic methods are: taking a case history,
inspection (face, hair, body, gait, tongue body, and coating),
auscultation (e.g., listening to the voice, breathing sounds,
qualityofacough),andpalpation(ofbody partsifindicated,
and in particular, pulse diagnosis). Pulse diagnosis involves
palpation of the radial artery of both wrists, to ascertain the
state of the vital substances of the body, the qi and blood, as
well as the various organ systems.
What I believe is also a distinguishing feature of CM
when juxtaposed to western medicine is the co-existence
of many and in some cases, seemingly contradictory,
theories: there is no imperative for one to be correct
or supersede another, perhaps reﬂective of the diﬀer-
ences in underpinning metaphysics of the two systems of
medicine.
2.2.BasicTheories. YinYangTheoryposits thattherearetwo
complementary yet opposite forces, termed Yin and Yang,
that form the basis of life. Health relies on a harmonious
balance of Yin and Yang and illness is seen as an imbalance
of these two vital forces. It was believed that Yin Yang
Theory originated with peasants’ observations of the change
in shadow and light on the two sides of a mountain with the
apparentpassageofthesuninthesky[3].TheconceptofYin
became synonymous with cold, rest, and night, and “Yang”
was used to describe heat, activity, and day [3, 4]. By way
of analogy it was incorporated in CM to describe the body.
For example, the exterior of the body was Yang in relation
to the interior which was Yin, the upper portion of the
body Yang in relation to the lower (Yin). It was also used to
describe the normal physiological functioning of the body as
well as pathological processes. Signs and symptoms could be
categorised as Yang (e.g., a loud barking cough with profuse
sputum) or Yin (in comparison, a weak cough with little
sputum expectorated). These concepts of Yin and Yang are
applied to the organ systems of the body. For example, there
is the notion of “Kidney Yin” and “Kidney Yang” denoting
diﬀerentaspectsofthe Kidney, as it is understood within CM
theory.
The notion of “qi” is central to CM: qi forms the basis of
all that is, including the human being and the environment.
Qiisbothamaterialconceptandafunctionalone.Materially
it can be thought of as a kind of subtle, rareﬁed “energy” of
essential life force that permeates the body and environment,
formingthematerialbasisofthebody.Inafunctionalsenseit
describes the activities of the “zang-fu” organ systems within
the body (discussed later). Though it is more complex than
this there are over 270 diﬀerent deﬁnitions of qi in one of
the oldest guiding CM textbooks, the Huang Di Nei Jing
[5]. Qi is believed to circulate within special conduits in
the body termed meridians and collaterals that connect all
parts of the body, including connecting the organ systems
with each other and their related sense organs. Along these
meridians lie special points termed “acupoints”, where the qi
ofthemeridiansisparticularlyconcentrated[6].Itisthrough
stimulationoftheseacupointswithneedlesthatacupuncture
has its eﬀect. There are several types of qi that perform
diﬀerentfunctions,andeach“zang”organhasitsownqialso.
Meridian Theory is the key theory to describe the distri-
bution of the meridians, their functioning in a physiological
sense, and the interrelationships between the meridians and
the organs they connect to. There are 12 main meridians
in the body, each connecting with one of the major “zang-
fu organs” in the body (and named after it) (see later).
Qi circulates through the meridians in a deﬁned sequence
(beginning with the Lung meridian and ending in the Liver
Meridian), and each meridian is at a peak energetically
duringaspeciﬁctwo-hourperiod.MeridianTheoryprovides
the basis for understanding both the physiological and
pathological functioning (in illness) of the human [7].
Five-Phase (or Five-Element) Theory posited that there
were ﬁve elements within nature that are fundamental to
life: wind, metal, ﬁre, earth, and water, that were taken to
symbolise behaviour of phenomena in nature. By observing
the elements in nature, analogies were drawn with respect toCholesterol 3
the functioning of the body in health and disease. The theory
was used to categorise phenomena including the seasons,
colours, tastes, body organs, sense organs, and emotions.
For example, the element “wood” was related to the season
of spring, the Liver organ, the eye (sense organ), the
tendons and nails, the sour taste, the colour green, and the
emotion of anger. Through analysis of signs and symptoms,
it is possible to identify involvement of particular elements
(and therefore organ systems). The ﬁve elements and their
associated organ systems exist in speciﬁc relationship to
each other. These relationships provided a model of under-
standing how disharmony in one organ system aﬀect others.
Through an understanding of these inter-relationships, the
practitioner treats not only the element/organ involved
in pathology, but often those organs related via these
relationships.
Zang Fu Theory is the major theory to describe the
organ systems within the body, termed “zang-fu” organs.
The zang organs are the “solid” organs: the Heart, Lung,
Kidneys, Liver, and Spleen. Each zang organ is connected to
a “hollow” fu organ via the meridian system, for example
the Liver with the Gallbladder and the Kidney with the
Bladder. Each zang organ is better thought of as a functional
organ system, with some functions very diﬀerent to those
in biomedicine, though they do encompass these in modern
practice. For example, each zang organ is also connected to
a sense organ, and its condition is reﬂected in an external
part of the body. The Liver is related to the eye (and sense
of sight) via the meridian connections, and the condition of
the Liver is reﬂected in the nails. Thus, it is often the case
in conditions of the eye that the Liver is treated in CM. The
function of the Liver is to ensure the “free ﬂow” of qi around
the body and to “store blood”. It plays an important role in
harmonising the emotions via this ability to ensure qi ﬂow is
smooth.
Yin Yang Theory becomes combined with Zang Fu
Theory in descriptions of pathology of the zang-fu organs.
For example, there is a Yin and a Yang aspect of the Kidney.
TheKidneyYinand/ortheKidneyYangcanbecomedeﬁcient
(inadequate)—in such cases, the syndrome would be termed
“Kidney Yin deﬁciency” or “Kidney Yang deﬁciency” respec-
tively.
Withrespecttotheunderstandingofaetiologyofdisease,
CM recognises external causes, internal (particularly relating
to the emotions) causes, and those that are noninternal and
nonexternal (e.g., trauma). There are six climatic factors
in nature: wind, ﬁre, summer-heat, dryness, cold, and
dampness, that if occurring out of season or with particular
force, and the person is susceptible, can become aetiological
factors in disease. By way of analogy, particular symptoms
and signs may be seen as evidence of the presence of such
aetiological factors internally. Internal dampness, for exam-
ple, can manifest as discharges (e.g., sputum) or oedema.
Each organ system has a related emotion which, if excessive
or prolonged, can cause problems in its related organ, for
example, anger and the Liver. Conversely pathology in a
particular organ may manifest as displays of the particular
related emotion. Emotions are seen as important aetiological
factors in disease.
3. Components of the Cardiovascular
System inChineseMedicine
In order to understand how hypercholesterolemia is concep-
tualised in CM, it is necessary to understand the components
of the cardiovascular system, in particular the Heart and its
relationships to other organs. The Heart (“Xin” in Chinese)
is the central zang-fu organ involved in the cardiovascular
system, with the other zang-fu organs assuming roles due to
theinterdependentrelationshipsbetweenthem.Accordingto
Meridian Theory, a number of the meridians and collaterals
pass through the Heart including the Heart meridian, Small
Intestine meridian (thepaired fu organof theHeart),Kidney
meridian, and Spleen meridian [7]. As a consequence of the
interdependent relationships, dysfunction of the Heart may
aﬀect other zang-fu organs and vice versa. The Heart is said
to be the “commander of blood” and “dominates the blood
andthevessels,”aphorismsidentifyingtheHeartasthemajor
organresponsibleforbloodcirculation.Heart qi providesthe
motive force for the heartbeat [6].
The Heart has a much broader role than blood cir-
culation. The Heart is understood to “house the shen”o r
“house the mind”. Shen, variously translated as “spirit” or
“vitality”, refers broadly to the exterior manifestation of
physiological functioning of the body and in a narrower
sense, to consciousness and mental functioning, including
memory, perception, and thinking [3, 6]. A quote from
the ancient Chinese text, the Huang Di Nei Jing Su Wen (
The Yellow Emperor’s Classic of Internal Medicine: Basic
Questions) illustrates this:
“The heart is the sovereign of all organs and
represents the consciousness of one’s being.
It is responsible for intelligence, wisdom, and
spiritual transformation [8].”
Conditions suchasinsomnia andpoor memoryareoften
seen to relate to the Heart and its ability to “house the shen”;
a notion that is not really consistent with how insomnia
is understood in western medicine. Due to the broader
understanding of the function of the Heart in CM, if there is
a problem with the Heart, this does not automatically equate
with a cardiac disorder though of course it can encompass
this. Nonetheless, certain clinical disorders in ancient CM
literature were clearly describing CVDs as we understand
them in biomedicine. However the signs and symptoms
described under that clinical descriptor may not have been
exclusivetoheartdisease.Forexample,thedisorderof“Chest
BiSyndrome(heretheword“Syndrome”isusedinamanner
analogous to how it is used in western medicine, rather
than as it is typically used in Chinese medicine: to denote
an underlying pattern of disharmony)” (“Jue Xin Pain”),
described in the ancient text the Huang Di Nei Jing [9],
describes the condition of pain in the chest but several
biomedical clinical entities may fall under this umbrella
such as angina, myocardial infarction, gastritis, esophagitis,
globus hystericus.
The Heart “rules” emotional activities as well as mental
activities. The particular emotion related to the Heart is joy;
thus, if there is over-excitement that is sudden or prolonged,4 Cholesterol
this can be damaging to the Heart. The state of the Heart is
not only reﬂected in the pulse, but also in the complexion.
If the face is very pale, this may be a sign of “Heart- blood
deﬁciency” (though a person may or may not be diagnosed
as anaemic). Since the Heart connects to the tongue via the
internal meridians, incoherent speech may be seen as a sign
of pathology of the Heart [10].
It can be argued that the four other “zang” organs (Lung,
Kidney, Liver, and Spleen) constitute the cardiovascular
system due to their various related functions and their
relationships with the Heart. Due to the close relationship
between qi and blood (blood carries qi, qi is a component
of blood), the Lung, known as the “commander of qi” and
responsible for qi circulation, is also involved in promotion
of blood circulation [6]. The Liver is involved by virtue
of its role in regulating or ensuring the free ﬂow of qi
around the body and its role in regulating blood volume
(“storing blood”). There is some consistency between this
understanding of organ connections in CM and that within
biomedicine: the connection between the heart and the liver
organinbiomedicineisillustratedinportalhypertension,for
example. According to CM, one of the Kidney’s roles is in
ﬂuid metabolism. According to theory, the Kidney and Heart
share a special relationship, keeping each other “in check”
[6]. The link between Heart and Kidney in CM is shared
in biomedicine with the recognition of the renal-aldosterone
system in hypertension and heart disease [10]. The Spleen
generates “nutrient qi” that circulates through the meridian
system and constitutes blood. A function of the Spleen in
CM is to “hold” blood within the vessels; if the Spleen
is operating suboptimally, bleeding disorders may occur
[6].
Thus is can be seen that although the Heart is the major
organ in the cardiovascular system within CM, the other
major “zang” organs are involved by way of their various
relationships with the Heart.
4. Hypercholesterolemia inChineseMedicine
4.1. Aetiology and Pathogenesis. There is no ancient prece-
dence in CM for treatment of hypercholesterolemia; it is a
relatively modern, biomedically deﬁned clinical entity. The
understanding of aetiology and pathogenesis of hypercholes-
terolemia has not been built up over hundreds of years of
empirical observation, unlike other diseases or disorders.
Explanations of aetiology and pathogenesis according to
CM theory have developed relatively recently. Nonetheless,
syndrome diﬀerentiation has been applied, and various
authors have reported typically 3–8 diﬀerent syndromes
of hypercholesterolemia [11–14]. As mentioned previously,
treatment with CHM or acupuncture is typically aimed at
the disease/disorder and the CM syndrome.
The pathogenesis of hypercholesterolemia is believed to
involve the production of internal “dampness” and “phlegm”
that leads to internal obstruction including “qi stagnation”
and“blood stagnation”. The threemain zangorgansinvolved
are believed to be the Spleen, Liver, and Kidney [11]
though the Heart is obviously involved by virtue of the
fact that it controls the circulatory system. The fundamental
pathogenesis of hypercholesterolemia according to Fu [14]i s
both Spleen and Kidney deﬁciency and “phlegm” and “blood
stagnation.” Spleen qi deﬁciency is believed to be the most
important factor in pathogenesis of hypercholesterolemia,
consistent with theory which holds that “dampness” and
“phlegm” are produced by a malfunctioning Spleen [14].
The mechanisms by which the aetiological factors create the
pathogenesis of the disorder are complex. These factors are
believed to include poor diet that leads to malfunctioning of
theSpleenandproductionofinternaldampnessandphlegm.
Emotional upsets, in particular anger, may lead to Liver qi
stagnation [12]. Qi stagnation can lead to blood stagnation.
Kidney and Spleen Yang deﬁciency can also lead to internal
dampness [12]. Liver and Kidney Yin deﬁciency may also be
involved [11].
InCM,phlegm(Chinese“tan”)isconsideredasecondary
pathogenic factor that is both a product and cause of disease
created by a dysfunction of one or more of the zang organs
involved in ﬂuid metabolism in the body. These organs
include the Spleen, the Kidney, and the Lungs. Ancient texts
described phlegm as a process of condensing and congealing
[15]. More modern texts distinguish between tangible and
intangible forms of phlegm. An example of tangible phlegm
is nasal discharge whilst an example of intangible phlegm
is (the manifestation of) dizziness. The concept of phlegm
is related to “dampness”; phlegm originates from it [15].
Phlegm creates problems in the body by stagnating or
blocking.Forexample,ifphlegmblockstheLungs,asthmatic
breathing may result. If it blocks the meridians, stroke may
result [6]. It is not diﬃcult to see the potential relationship
between an atheromatous plaque on a blood vessel wall and
serum cholesterol and the concept of phlegm in CM.
Blood stasis (Chinese “yu xue”) refers to a retardation of
blood circulation, locally or systemically. Here’s where the
pathogenesis gets interesting. Qi and blood stagnation may
occur as a result of phlegm “blocking.” Qi stagnation may
also be part of the pathogenesis of phlegm. Qi stagnation
may lead to blood stagnation and vice versa (blood carries
qi); qi and blood stagnation often occur concurrently. A
deﬁciency of qi in the body may lead to a deﬁciency of
blood; qi provides the motive force for blood circulation,
so if it is deﬁcient, blood circulation may become retarded.
Pathogenic cold (i.e., external and enters the body or is
internally generated) may block the ﬂow of qi and blood,
leading to blood stasis. Pathogenic heat may “congeal” the
blood, leading to blood (and qi) stasis. Key organs involved
are the Heart (“ruler of blood”) and the Liver (“stores the
blood”, involved in circulating qi around the body freely).
Thus, there are many pathomechanisms by which blood
stasis may occur according to CM. Signs and symptoms
that are characteristic of “blood stagnation” include a purple
tongue body or petechiae on the tongue, a particular type of
pulse quality, purplish lips, a dark complexion and, in the
case of pain, a stabbing quality in a ﬁxed location [6].
Through analysis of signs and symptoms, the CM prac-
titioner diagnoses the underlying pattern(s) of disharmony.
Herbs are then chosen to make up the medicinal formula
accordingly. Chinese herbs are categorised according to theirCholesterol 5
functions and eﬀects on the body (i.e., in turn determined
by the properties, nature, and temperature characteristics of
the herbs). There are several categories of herbs that address
or resolve dampness and phlegm in the CM Materia Medica.
In keeping with CM theory of treating the root cause, other
herbs will be chosen to address the root cause of the phlegm,
for example, Spleen qi deﬁciency. There are also herbs that
have a speciﬁc function of addressing “qi stagnation” whilst
others address “blood stasis” (those that promote qi and
blood circulation). Again, herbs would be added to address
the root cause of the blood stasis. If the blood stasis was due
to “internal cold,” herbs of a warm nature that “warm the
interior” may be added (and herbs overly cold in terms of
temperature characteristic avoided, in general).
4.2. Underlying Patterns of Disharmony. Attempts have been
made to apply the concept of pattern diﬀerentiation (of
syndromes) to hypercholesterolemia (bian zhen lun zhi).
Various texts have listed between three and eight sub-
categories (CM syndromes) of hypercholesterolemia [11–
13], including “Liver Qi Stagnation and Spleen Deﬁciency
pattern,” “Internal Dampness-Heat pattern,” and “Spleen
and Kidney Yang Deﬁciency pattern” [11–13]. One Chinese
study attempted to empirically ascertain the CM syndromes
of hypercholesterolemia, however unfortunately the study
population contained patients with a myriad of concomitant
cardiovasculardisorders,renderingitimpossibletomakeany
conclusions regarding syndromes of hypercholesterolemia
[14]. An interrater reliability study of CM diagnosis in
45 hypercholesterolemic Australians who were otherwise
healthy did not ﬁnd 3–8 neat CM syndromes, instead
identifying over 15 diﬀerent syndromes over the study
population [16]. Little agreement on syndrome diagnosis
according to Zang-Fu Theory was found between three CM
practitioners [16]. These ﬁndings lead the researchers to
question the applicability of syndrome diﬀerentiation to
hypercholesterolemia; the syndromes identiﬁed may have
simply reﬂected the state of that patient’s body at the
time or their constitutional pattern and not reﬂected the
pathogenesis relating to hypercholesterolemia [16].
It is not yet established with certainty that the concept
of diﬀerentiation of CM syndromes is in fact applicable to
a condition such as hypercholesterolemia. It is possible that
hypercholesterolemia is characterised by a complex mixture
of syndromes. It is also possible that the underlying path-
omechanism of hypercholesterolemia is similar for all peo-
ple, that is, it is not syndrome-speciﬁc [16]. More research
is needed. Why this is important is that the establishment
(or otherwise) of CM syndromes of hypercholesterolemia
has direct relevance to the formulation of CHMs; CHMs are
generally formulated to address the speciﬁc CM syndrome
of a disease/disorder. There are particular categories of
herbs that will be chosen to speciﬁcally address particular
CM syndromes and particular aspects of pathogenesis of
a condition. For example, if a diagnosis of “Spleen Qi
Deﬁciency” is made, then herbs that “tonify” or strengthen
the “Spleen” will be chosen from the Materia Medica. If
a diagnosis is made of “Liver Yin deﬁciency” then quite
diﬀerent herbs will be chosen to address this. If there is
“blood stagnation”, then herbs from the category of herbs
that promote blood circulation will be chosen. Chinese
medicinal formulae are created according to particular rules
that are logical and structured within the framework of CM.
5. Scientiﬁc Evidenceabout Chinese Herbs
that Lower Cholesterol
Despite the uncertainty with respect to whether or not or
which CM syndromes of hypercholesterolemia exist, what
is known is that several Chinese herbs have been shown
to have positive eﬀects on lowering cholesterol. The list
is extensive and includes the following: Dan Shen (Radix
Salvia Miltiorrhiza), San Qi (Panax Notoginseng), Shan Zha
(Fructus Crataegi), He Shou Wu (Polygonum Multiﬂorum
[Polygonaceae]), Huang Lian (Coptis Chinensis), Da Suan
(Bulbus Alli Sativi, garlic), Bai Guo (Ginkgo Biloba), Dang
Gui (Angelicae Sinensis), Sheng Jiang (Rhizoma Zingiber
Oﬃcinalis Recens, fresh ginger rhizome), Ge Gen (Radix
Puerariae), Jue Ming Zi (Semen Cassiae), Gou Qi Zi
(Lycium Barbarum), Pu Huang (Pollen Typhae), Du Zhong
(Cortex Eucmmiae Oppositae), Shan Yao (Radix Dioscoreae
Oppositae), Fu Ling (Sclerotium Poriae Cocos), Bai Zhu
(Rhizoma Atractylodis Macrocephalae), Gua Lou (Fructus
TrichosanthisKirlowii),GouQiZi(FructusLyciiChinensis),
Sheng Di Huang (Radix Rehmanniae Glutinosae), Sang Ji
S h e n g( R a m u l u sL o r a n t h iS e uV i s c i ,N uZ h e nZ i( F r u c t u s
Ligustri Lucidi), Ju Hua (Flos Chrysanthemi Morifolii), and
Ze Xie (Rhizoma Alismatis) [12, 17, 18].
Berberine, an alkaloid originally isolated from the Chi-
nese herb Huang Lian (Coptis Chinensis), has been found to
lower cholesterol in hypercholesterolemic patients and up-
regulate hepatic LDL receptor expression [19]. It also has
antihypertensive and antiarrhythmic actions [20]. Jue Ming
Zi (Semen Cassiae) has been found to signiﬁcantly increase
HDL levels in hypercholesterolemic mice models compared
with placebo [21]. In addition, Jue Ming Zi has been found
to lower blood pressure [17]. Research has demonstrated
that Pu Huang (Pollen Typhae) lowers serum cholesterol
[18]. Ge Gen (Radix Puerariae) has been found to increase
HDL cholesterol in patients with coronary heart disease
[22]. Animal research has demonstrated that treatment of
hypercholesterolemic rats with Pu Huang powder over six
weekssigniﬁcantlyreducedserumcholesterolcomparedwith
placebo[23].ExtractofMingDangShenhasalsobeenfound
found to signiﬁcantly reduce serum cholesterol in rats [24].
Extract of Gou Qi Zi (Lycium Barbarum) has been found to
have hypolipidemic, hypoglycaemic, and antioxidant eﬀects
in animal models; the antioxidant eﬀect and hyperlipidemic
eﬀectwerestrongerinthewaterdecoctionandcrudeextracts
compared with the polysaccharide fractions preparation
whereas the opposite was true of the hypoglycaemic eﬀect
[25]. Bai Guo (Gingko Biloba) was found to positively
aﬀectreperfusion-inducedventriculararrhythmiainanimals
(though not the duration of the arrhythmia) and decreased
the ischemia reperfusion-induced increase in CPK compared
with controls [26].6 Cholesterol
As reported by Valli and Giardina [18], several stud-
ies have found that garlic (Chinese Da Suan) reduces
serum cholesterol between 5% and 15% [27–30]. How-
ever, Berthold and Sudhop [31] caution that there is less
convincing evidence of the eﬀect of garlic preparations in
lowering lipids on the basis of rigorously designed studies.
Other studies have not found such positive results of
garlic: one randomised controlled trial failed to show a
signiﬁcant diﬀerence from placebo in lowering cholesterol
[32], and a meta-analysis (of ﬁve studies) failed to show a
signiﬁcant diﬀerence in LDL and HDL cholesterol compared
with placebo [29]. In vitro and animal studies support a
cholesterol lowering eﬀect of Da Suan [33] and an anti-
atherosclerotic eﬀect [34] that is independent of lipid levels
[18, 35, 36]. Garlic has been found to have ﬁbrinolytic and
antiplatelet activity and antihypertensive activity [18].
Tea consumption has been associated with lower CVD
risk, and several animal studies have demonstrated a choles-
terol lowering eﬀect of both green and black teas [37].
Maron and colleaguesfound that intake of a green tea extract
enhanced with theaﬂavin signiﬁcantly lowered LDL choles-
terol and total cholesterol compared with baseline in patients
withmild-moderatehypercholesterolemia[37].Mechanisms
of action of green tea likely include upregulation of LDL
receptors in hepatic HPG2 cells [38].
Red yeast rice appears to show promise as a herbal
alternative for cholesterol lowering. Journoud and Jones [39]
provide a very good review. Red yeast rice is produced by
fermentation of rice with a speciﬁc strain of red yeast called
Monascus purpureus. It has been used in China for centuries
to make rice wine and ﬂavour food and used in traditional
medicine to treat digestive disorders [39–41]. Red yeast
rice has been shown to lower total cholesterol by 13–26%,
LDL cholesterol by 21–33% and triglycerides by 13–34%,
and increase HDL cholesterol by 8–14% [39, 41]. Animal
studies provide evidence that red yeast rice may reduce
atherogenesis and induce nitric oxide-mediated endothelial-
dependent vasodilation [42, 43]. It was banned from the
US dietary supplement market in 2001 by the US Food and
Drug Administration because one of the active constituents,
Monacolin K (present in red rice that has been fermented
with Monascus purpureus Went.), is the same as lovostatin
that inhibits HMG-CoA reductase [40]. Other constituents
ofredyeastriceincluding plantsterolsincluding β-sitosterol,
campesterolandsaponin,isoﬂavones,seleniumandzincmay
contribute to the cholesterol lowering ability of red yeast
rice [40, 44] though Journoud and Jones [39] assert that
generally there is little information about secondary bioac-
tive constituents. Other possible mechanisms by which it
may act include improving circulatory cholesterol clearance
and inhibiting dietary cholesterol absorption [42] though
the weight of evidence favours its inhibition of HMG-CoA
reductase as the major mechanism [39]. Other types of
pigmented rice including red and black rice show promise
as cardio-protective functional foods [39]. Animal studies
(rabbits) have shown that red and black rice can signiﬁ-
cantly reduce atherosclerotic plaque formation, raise HDL
c h o l e s t e r o la n da p o p r o t e i nA - Il e v e l sa sw e l la sr e d u c el i v e r
reactive oxygen species and aortic malondialdehyde levels,
and increase liver total antioxidant capacity and erythrocyte
superoxidedismutaseactivity[45].Activeconstituentsofred
rice have been found to have radical-scavenging properties
[46].
In terms of properties (temperature and taste char-
acteristics) of the herbs as understood according to CM
pharmacology theory, several of these herbs that lower
serum cholesterol have “blood invigorating” or circulation-
promoting properties including Dan Shen (Radix Salvia
Miltiorrhiza), San Qi (Panax Notoginseng), (Dang Gui
Angelica Sinensis), and Pu Huang (Pollen Typhae). Other
h e r b sh a v ea ne ﬀect on eliminating “dampness” or “phlegm”
such as Bai Guo (Ginkgo Biloba) and Huang Lian (Coptis
Chinensis). Readers will remember from previous sections
of the paper that from the CM theory perspective, it is
believed that “blood stagnation” and “phlegm” are involved
in the pathogenesis of hypercholesterolemia. Other herbs
have actions that, from the CM perspective, are consistent
with an ability to address the pathology underlying hyper-
cholesterolemia. For example, He Shou Wu (Polygonum
Multiﬂorum [Polygonaceae]) is a herb that “nourishes
blood” and “toniﬁes” the Kidney and Liver Yin. Jue Ming
Zi (Semen Cassiae ) belongs to the category of “Herbs that
Drain Fire” and may address a syndrome of “Excess of Liver
Yang” that is due to an underlying Liver and Kidney Yin
deﬁciency (it also has a blood pressure lowering eﬀect).
Da Suan (garlic) and Sheng Jiang (fresh ginger) are warm
in terms of temperature characteristic (according to CM
pharmacology) and may address a syndrome where there is
“interior cold” [17].
From a western pharmacological perspective, many
Chinese herbs (including those mentioned previously) have
other cardiovascular eﬀects including reduction of blood
pressure, ionotropic eﬀects, cardiotonic eﬀects, and cardio-
protective eﬀects including positive eﬀects on cardiac per-
fusion, reduction of infarct size as a result of myocardial
ischaemia, antioxidant eﬀects, and improvements in other
cardiovascular parameters [9, 17, 18, 20, 47, 48]. However
not all eﬀects of Chinese herbs on the cardiovascular system
are positive, and drug-herb interactions are known [9].
Scientiﬁc evidence in relation to cholesterol-lowering
activity of particular herbs is useful to the CM practitioner.
Those herbs identiﬁed as lowering cholesterol belong to a
range of categories of herbs within the CM Materia Medica.
Thus, if a CM syndrome diagnosis is made in a patient with
hypercholesterolemia, a choice may be made of the appro-
priate herbs that address the CM syndrome identiﬁed from
amongst the many herbs that lower cholesterol, consistent
with CM theory.
5.1. Scientiﬁc Research into CHM. The eﬀects of various
Chinese herbal medicinal formulae on cardiovascular risk
factorshave been assessed in numerous studies though much
of the research is limited to Chinese language publications.
Several animal studies have demonstrated the beneﬁcial
eﬀects of various CHMs in lowering cholesterol [49–53].
Other studies have demonstrated beneﬁcial eﬀects of herbal
formulae on mechanisms involved in the atheroscleroticCholesterol 7
process including prevention of platelet adhesion and
aggregation [54], enhancement of nitric oxide synthetase
mRNA expression and inhibition of Endothelin mRNA
expressioninthevascularwallofatheroscleroticrabbits[55],
improvement of vascular endothelial function in humans
[56] and reduction in the extent of the atherosclerotic lesion,
anddecreaseinseverityofintimalproliferation(theformula
tested was Shexian Baohe Pill. The study also found a
reduction in serum cholesterol and LDL cholesterol but not
HDL cholesterol or triglycerides) [51].
Lin and colleagues [49] found that intra-abdominal
treatment of hypercholesterolemic rats and quails with
“Kangshou liquid” (containing herbs Jiao Gu Lan, Huang
Qi, Bai Zhu, Ze Xie, Dan Shen) was associated with a
signiﬁcant reduction in serum cholesterol and triglycerides
compared with placebo. From the Chinese pharmacology
perspective, the herbs in this prescription are herbs that
address Spleen qi deﬁciency (Jiao Gu Lan, Huang Qi, Bai
Zhu) and dampness (Ze Xie, Bai Zhu) and blood stagnation
(Dan Shen). Treatment of hypercholesterolemic quails with
Dan Ze Compound (herbs Dan Shen, Ze Xie, Jue Ming Zi,
Shan Zha, Gua Lou Pi) was associated with a signiﬁcant
increase in HDL cholesterol compared with placebo [57].
The herbs in this prescription address blood stagnation
(Dan Shen, Shan Zha), dampness (Ze Xie), Liver yang (Jue
Ming Zi), and phlegm (Gua Lou Pi). The eﬃcacy of these
examples of formulae reported above lend some support
to a pathomechanism involving dampness or phlegm and
blood stagnation. On the other hand, it could also be argued
that since the majority of these herbs individually have been
shown to lower cholesterol using western scientiﬁc research
methodology, the mechanism by which the herbal formulae
work is entirely explained by western pharmacological
evidence. The two types of evidence may support each other.
Tuandcolleagues[58]foundthattreatmentofhyperlipi-
demicratswithacardiovascularprotectivemixture“CVPM”
(containing predominantly blood circulation-promoting
herbs) signiﬁcantly lowered total and LDL cholesterol and
malondialdehyde levels, suggesting that CPVM is able to
inhibit peroxidation of lipids compared with controls [58].
In addition, in vitro investigation of aorta samples of
hyperlipidemicratsdemonstratedthatCVPMhadprotective
eﬀects on the vascular endothelium and that CVPM could
also stimulate proliferation of endothelial cells [58]. Since
according to CM theory this formula contains predom-
inantly blood circulation-enhancing herbs, this particular
study goes some way to extending the notion of “blood
invigoration” beyond simply cardiotonic eﬀects. CM theory
should not stand still, simply resting on texts written two
thousand years ago. Through exploring potential intersec-
tions of knowledge between CM and western medicine,
scientiﬁc research has the potential to extend CM theory.
Although not related to hypercholesterolemia, another
interesting piece of research that examines intersections
of knowledge is a study that investigated the relationship
between CM syndromes related to “blood” and levels of
platelet activation molecules [59]. Li and colleagues found
that levels of platelet-activation molecules CD62P and CD63
were signiﬁcantly raised in psoriatic patients compared with
controls [59]. They subcategorised psoriatic patients into
three CM syndromes (“blood heat”, “blood dryness,” and
“blood stasis”) and found that CD62P and CD63 levels
were signiﬁcantly higher in patients with “blood stasis”
syndrome compared with “blood heat” syndrome (the order
of correlation was: blood stasis syndrome > blood dryness
syndrome > blood heat syndrome) [59]. These results link
objective western biochemical evidence of platelet activation
(that plays an important role in higher blood viscosity,
endothelial cell injury, and abnormal microcirculation) and
the CM theory notion of “blood stagnation” as evidenced by
clinical patterns of signs and symptoms. What is interesting
from a CM perspective is that both “blood dryness” and
“blood heat” may be earlier stages in the pathogenesis of
“bloodstagnation”(thoughtheyarenotthesolepathwaysby
which blood stagnation may occur and “heat in the blood”
may not always develop into blood stasis, according to CM
theory).
6. Conclusion
Treatment of heart disease has a long history in China.
The cardiovascular system in CM has several components
of which the Heart is central, however diﬀerences can be
seen between the traditional concept of the Heart in CM
and the biomedical one. The Heart has an interdependent
relationship with the other zang-fu organs. CM theory and
pattern diﬀerentiationarenow being appliedtobiomedically
deﬁned clinical entities such as hypercholesterolemia. CM
theory has been applied to conceptualise the aetiology and
pathogenesis of hypercholesterolemia, which includes the
notions of phlegm and blood stagnation. There is a potential
problem with this: hypercholesterolemia has no historical
precedent of treatment prior to the rise of modern medicine.
The appropriateness of applying pattern diﬀerentiation to
hypercholesterolemia has not been established, despite the
claims of authoritative texts. More investigations are needed
with respect to this.
With the imperative to become evidence based, CM is
now being scrutinised in waysthatit hasnot been previously.
At a more basic level, modern science has demonstrated
that a variety of individual Chinese herbs have cholesterol-
loweringproperties,andthereareexamplesofclinicalstudies
that have assessed the eﬃcacy of medicinal formulae in
lowering raised cholesterol. At a more sophisticated level,
some researchers are challenging some of the very assump-
tions upon which CM is based and seeking intersections of
knowledge between CM and biomedicine that may extend
CM theory. In relation to hypercholesterolemia and CVD
more generally, there is still much to explore.
References
[ 1 ]K .A .O ’ B r i e na n dC .C .L .X u e ,“ T h et h e o r e t i c a lf r a m e w o r k
of Chinese medicine,” in A Comprehensive Guide to Chinese
Medicine, P.-C. Leung, C. C. L. Xue, and Y.-C. Cheng, Eds.,
World Scientiﬁc, River Edge, NJ, USA, 2003.
[2] V. Scheid, Chinese Medicine in Contemporary China. Plurality
and Synthesis, Duke University Press, London, UK, 2002.8 Cholesterol
[3] G. Maciocia, The Foundations of Chinese Medicine, Churchill
Livingstone, New York, NY, USA, 1989.
[4] H. Beinﬁeld and E. Korngold, Between Heaven and Earth. A
Guide to Chinese Medicine, Ballantine Books, New York, NY,
USA, 1991.
[ 5 ]Y .H .Z h a n ga n dK .R o s e ,AB r i e fH i s t o r yo fQ i , Paradigm
Publications, Brookline, Mass, USA, 2001.
[ 6 ]J .C a i ,G .C h a o ,D .C h e ne ta l . ,E d s . ,Advanced Textbook on
Traditional Chinese Medicine and Pharmacology. Vol. I,S t a t e
Administration of Traditional Chinese Medicine, New World
Press, Beijing, China, month 1995.
[7] J. Li-Ling, “The Jing-Mai connections of the heart,” Interna-
tional Journal of Cardiology, vol. 89, no. 1, pp. 1–11, 2003.
[8] N. Maoshing, The Yellow Emperor’s Classic of Medicine-A New
Translation of the Neijing Suwen with Commentary, Shambala,
Boston, Mass, USA, 1995.
[9] P. Davidson, K. Hancock, D. Leung et al., “Traditional Chinese
Medicine and heart disease: what does Western medicine
and nursing science know about it?” European Journal of
Cardiovascular Nursing, vol. 2, no. 3, pp. 171–181, 2003.
[10] K. A. O’Brien and R. Z. Luo, “Myocardial ischaemia: causes,
symptoms and treatment,” in Chinese Medicine Perspectives on
MyocardialIschaemia,N ovaScienceP ublishers,N ewY ork,NY ,
USA, 2010.
[11] J. Hou, Traditional Chinese Treatment of Cardiovascular Dis-
ease, Academy Press, Beijing, China, 1995.
[12] S. Becker, B. Flaws, and R. Casanas, The Treatment of
Cardiovascular Disease with Chinese Medicine, Blue Poppy
Press, Boulder, Colo, USA, 2005.
[13] Drug Policy Bureau of Ministry of Health, “New Drug (Chi-
nese Medicine) Pre-Clinical Research Guidelines,” Ministry of
Health, Beijing, China, 1993.
[14] Y. Fu, “Clinical assessment of hypercholesterolaemia,” Chinese
Journal of Information on Traditional Chinese Medicine, vol. 6,
no. 8, p. 74, 1999.
[15] V. Scheid, “Shaping Chinese medicine: two case studies from
contemporary China,” in Innovation in Chinese Medicine,E .
Hsu, Ed., Cambridge University Press, Cambridge, UK, 2001.
[16] K. A. O’Brien, E. Abbas, J. Zhang et al., “An investigation into
thereliabilityofChinesemedicinediagnosisaccordingtoeight
guiding principles and Zang-Fu theory in Australians with
hypercholesterolemia,” Journal of Alternative and Complemen-
tary Medicine, vol. 15, no. 3, pp. 259–266, 2009.
[17] D. Bensky and A. Gamble, Chinese Herbal Materia Medica,
Eastland Press, Seattle, Wash, USA, 1993.
[18] G. Valli and E.-G. V. Giardina, “Beneﬁts, adverse eﬀects
and drug interactions of herbal therapies with cardiovascular
eﬀects,” Journal of the American College of Cardiology, vol. 39,
no. 7, pp. 1083–1095, 2002.
[19] W. Kong, J. Wei, P. Abidi et al., “Berberine is a novel
cholesterol-lowering drug working through a unique mech-
anism distinct from statins,” Nature Medicine, vol. 10, no. 12,
pp. 1344–1351, 2004.
[20] W. H. Frishman, S. T. Sinatra, and M. Moizuddin, “The
use of herbs for treating cardiovascular disease,” Seminars in
Integrative Medicine, vol. 2, no. 1, pp. 23–35, 2004.
[21] W. X. Chen, G. S. Diao, W. J. Jiang, and L. T. Liang, “The
inﬂuenceofjuemingzionmicewithhighcholesterol,”Journal
Chinese Herbal Medicine, p. 72, 1989.
[22] H.-W. Yue and X.-Q. Hu, “The medicinal value of Radix Puer-
ariea and Puerarin in treating diseases of the cardiovascular
system,” Chinese Journal of Integrative Medicine, vol. 3, no. 3,
pp. 234–238, 1997.
[23] W. H. Ren, G. Q. Huang, D. M. Xu et al., “Research on
the eﬀect of pu huang and its preparations on hypercholes-
terolemia and the function of macrophages,” Shanghai Zhong
Yi Yao Za Zhi, vol. 8, pp. 46–48, 1989.
[24] H. P. Wu, Y. L. Hua, P. L. Xi et al., “Anti-oxidant eﬀect of
ming dang shen in rats with hypercholesterolemia,” Journal of
Nanjing TCM College, vol. 10, no. 4, pp. 33–34, 1994.
[25] Q. Luo, Y. Cai, J. Yan, M. Sun, and H. Corke, “Hypoglycemic
and hypolipidemic eﬀects and antioxidant activity of fruit
extracts from Lycium barbarum,” Life Sciences, vol. 76, no. 2,
pp. 137–149, 2004.
[26] A. Kurcok, “Ischaemia and reperfusion-induced cardiac
injury: eﬀect of two ﬂavonoid containing plant extracts pos-
sessing radical scavenging properties,” Naunyn-Schmiedeberg’s
Archives of Pharmacology, vol. 345, supplement, article R81,
1992.
[27] R. T. Ackermann, C. D. Mulrow, G. Ramirez, C. D. Gardner,
L. Morbidoni, and V. A. Lawrence, “Garlic shows promise
for improving some cardiovascular risk factors,” Archives of
Internal Medicine, vol. 161, no. 6, pp. 813–824, 2001.
[28] C. Silagy and A. Neil, “Garlic as a lipid lowering agent—a
meta-analysis,” Journal of the Royal College of Physicians of
London, vol. 28, no. 1, pp. 39–45, 1994.
[29] C. Stevinson, M. H. Pittler, and E. Ernst, “Garlic for treating
hypercholesterolemia: a meta-analysis of randomize clinical
trials,” Annals of Internal Medicine, vol. 133, no. 6, pp. 420–
429, 2000.
[30] S. Warshafsky, R. S. Kamer, and S. L. Sivak, “Eﬀect of garlic
on total serum cholesterol: a meta-analysis,” Annals of Internal
Medicine, vol. 119, no. 7, pp. 599–605, 1993.
[31] H. K. Berthold and T. Sudhop, “Garlic preparations for
prevention of atherosclerosis,” Current Opinion in Lipidology,
vol. 9, no. 6, pp. 565–569, 1998.
[32] H.A.W.Neil,C.A.Silagy,T.Lancasteretal.,“Garlicpowderin
the treatment of moderate hyperlipidaemia: a controlled trial
and meta-analysis,” Journal of the Royal College of Physicians of
London, vol. 30, no. 4, pp. 329–334, 1996.
[33] C. Y. Gao, Y. J. Xu, T. Lu et al., “Eﬀect of da suan su on
plasma and arterial wall camp in rabbits with experimental
hypercholesterolemia,” Zhongguo Zhong xi yi jie he za zhi
Zhongguo Zhongxiyi jiehe Zazhi, vol. 11, no. 4, pp. 227–228,
1991 (Chinese).
[34] A. N. Orekhov, V. V. Tertov, I. A. Sobenin, and E. M. Pivo-
varova, “Direct anti-atherosclerosis-related eﬀects of garlic,”
Annals of Medicine, vol. 27, no. 1, pp. 63–65, 1995.
[35] A. N. Orekhov and J. Grunwald, “Eﬀects of garlic on
atherosclerosis,” Nutrition, vol. 13, pp. 656–663, 1997.
[36] K. Prasad, S. V. Mantha, J. Kalra, and P. Lee, “Prevention of
hypercholesteroemicatherosclerosisbygarlic,anantioxidant,”
Journal of Cardiovascular Pharmacology and Therapeutics, vol.
2, pp. 309–320, 1997.
[37] D. J. Maron, G. P. Lu, N. S. Cai et al., “Cholesterol-lowering
eﬀect of a theaﬂavin-enriched green tea extract: a randomized
controlled trial,” Archives of Internal Medicine, vol. 163, no. 12,
pp. 1448–1453, 2003.
[38] C.Bursill,P.D.Roach,C.D.K.Bottema,andS.Pal,“Greentea
upregulates the low-density lipoprotein receptor through the
sterol-regulated element binding protein in HepG2 liver cells,”
Journal of Agricultural and Food Chemistry, vol. 49, no. 11, pp.
5639–5645, 2001.
[39] M. Journoud and P. J. H. Jones, “Red yeast rice: a new
hypolipidemic drug,” Life Sciences, vol. 74, no. 22, pp. 2675–
2683, 2004.Cholesterol 9
[40] D. Heber, I. Yip, J. M. Ashley, D. A. Elashoﬀ,R .M .E l a s h o ﬀ,
and V. L.W. Go, “Cholesterol-lowering eﬀects of a proprietary
Chinese red-yeast-rice dietary supplement,” American Journal
of Clinical Nutrition, vol. 69, no. 2, pp. 231–236, 1999.
[41] J. Wang, Z. Lu, J. Chi et al., “Multicenter clinical trial of the
serum lipid-lowering eﬀects of a Monascus purpureus (red
yeast) rice preparation from traditional Chinese medicine,”
Current Therapeutic Research, vol. 58, no. 12, pp. 964–978,
1997.
[42] C. Li, Y. Zhu, Y. Wang, J.-S. Zhu, J. Chang, and D. Kritchevsky,
“Monascus purpureus-fermented rice (red yeast rice): a
natural food product that lowers blood cholesterol in animal
models of hypercholesterolemia,” Nutrition Research, vol. 18,
no. 1, pp. 71–81, 1997.
[43] M.-R. Rhyu, D.-K. Kim, H.-Y. Kim, and B.-K. Kim, “Nitric
oxide-mediatedendothelium-dependentrelaxationofrattho-
racic aorta induced by aqueous extract of red rice fermented
with Monascus ruber,” Journal of Ethnopharmacology, vol. 70,
no. 1, pp. 29–34, 2000.
[44] J. Ma, Y. Li, Q. Ye et al., “Constituents of red yeast rice, a
traditionalChinesefoodandmedicine,”JournalofAgricultural
and Food Chemistry, vol. 48, no. 11, pp. 5220–5225, 2000.
[45] W. H. Ling, Q. X. Cheng, J. Ma, and T. Wang, “Red and black
rice decrease atherosclerotic plaque formation and increase
antioxidant status in rabbits,” Journal of Nutrition, vol. 131,
no. 5, pp. 1421–1426, 2001.
[46] T. Oki, M. Masuda, M. Kobayashi et al., “Polymeric procyani-
dins as radical-scavenging components in red-hulled rice,”
Journal of Agricultural and Food Chemistry, vol. 50, no. 26, pp.
7524–7529, 2002.
[ 4 7 ]K . - M .K o ,D .H .F .M a k ,P . - Y .C h i u ,a n dM .K .T .P o o n ,
“Pharmacological basis of ‘Yang-invigoration’ in Chinese
medicine,” Trends in Pharmacological Sciences, vol. 25, no. 1,
pp. 3–6, 2004.
[48] J. Sun, B. Kh Tan, S.-H. Huang, M. Whiteman, and Y.-Z. Zhu,
“Eﬀects of natural products on ischemic heart diseases and
cardiovascular system,” Acta Pharmacologica Sinica, vol. 23,
no. 12, pp. 1142–1151, 2002.
[49] Y. K. Lin, Z. J. Xie, M. X. Jiang, M. Yu, and S. Lin, “Eﬀect of
kangshou oral liquid on the level of blood lipids in animals,”
Journal of Fujian Medical College, vol. 29, no. 3, pp. 251–253,
1995 (Chinese).
[50] X. L. Lin, Z. X. Li, Y. H. Lu, S. Xie, and Y. L. Pan, “The eﬀect
of fu fang jiang zhi fen on the experimentally induced high
cholesterol in mice,” Guiyang College of Traditional Chinese
Medicine Journal, vol. 21, no. 2, pp. 58–59, 1999 (Chinese).
[51] X. Luo, Y. Li, W. Fan et al., “Experimental study on reducing
eﬀect of shexiang baoxin pill from damage of arterial wall
caused by hyperlipemia,” Zhongguo Zhong xi yi jie he za zhi
Zhongguo Zhongxiyi jiehe Zazhi, vol. 18, no. 8, pp. 486–489,
1998 (Chinese).
[52] X. H. Sun, S. L. Li, and G. H. Liu, “Experimental study of anti-
atherosclerosis treated with herbal jiang zhi wan,” Guiyang
College of Traditional Chinese Medicine Journal,v o l .1 4 ,n o .2 ,
pp. 57–59, 1992 (Chinese).
[53] Y. Zhu, C. Li, and Y. Wang, “Eﬀects of Xuezhikang on blood
lipids and lipoprotein concentrations of rabbits and quails
with hyperlipidaemia,” Zhongguo Yao xue za Zhi , vol. 30, no.
11, pp. 656–670, 1995 (Chinese).
[54] Y. Lei, K.-J. Chen, J.-G. Liu, and Y.-G. Xu, “Eﬀect of Xuefu
Zhuyu Pill on platelet activating factor expression in patients
with unstable angina pectoris,” Chinese Journal of Integrative
Medicine, vol. 8, no. 4, pp. 267–270, 2002.
[55] D. Shi, K. Chen, and Q. Zhang, “Eﬀect of puriﬁed Xuefu
Capsuleonendothelin,nitricoxidesynthetasegeneexpression
on vascular wall in atherosclerotic rabbits,” Chinese Journal of
Integrative Medicine, vol. 4, no. 2, pp. 123–125, 1998.
[56] F.-Q. Xu, L.-Z. Li, H. Xu, L.-F. Yao, K.-J. Chen, and N.-F. Shao,
“Eﬀects of Xiongshao Capsule on the function of vascular
endothelium of patients with cervial atherosclerosis,” Chinese
Journal of Integrative Medicine, vol. 10, no. 1, pp. 14–18, 2004.
[57] Y. Y. Gao, H. J. Shen, B. Zhang, H. Y. Jin, and R. X. Qiao,
“The eﬀect of dan ze compound on experimentally induced
hypercholesterolemia and arteriosclerosis in quails,” Beijing
University of Chinese Medicine Journal, vol. 17, no. 6, pp. 26–
28, 1994 (Chinese).
[58] Z. Tu, X. Han, X. Wang et al., “Protective eﬀects of CVPM
on vascular endothelium in rats fed cholesterol diet,” Clinica
Chimica Acta, vol. 333, no. 1-2, pp. 85–90, 2003.
[59] G. Y. Li, H. C. Liu, and G. P. Yin, “Relationship between
syndrome diﬀerentiation-typing and expression of platelet-
activation molecule CD62P and CD63 on platelets in psoriatic
patients,” Zhongguo Zhong xi yi jie he za zhi Zhongguo
Zhongxiyi jiehe Zazhi, vol. 17, no. 7, pp. 417–418, 1997
(Chinese).